During this in-person event, we are bringing together academic researchers from the Oncode Institute and industrial experts in the field of (immune-)oncology. Several experts in cancer drug discovery will present about topics such as: best practices for (early) target identification and validation, hit finding, and further downstream hit-to-lead activities.
Meet our experts in München on October 5-6 at the 17th Drug Discovery Innovation Programme.
The SLAS 2022 AI-Powered Drug Discovery Symposium brings us to the United Stated! Will we see you there?
We’re excited to be in Nice, France for the XXVII EFMC International Symposium on Medicinal Chemistry.